Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy
Clinical trial NCT06369467 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06369467
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-17
- Primary completion
- 2027-08-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.